Annual Accounts Receivable
$901.00 K
+$181.00 K+25.14%
31 December 2023
Summary:
Precision BioSciences annual accounts receivable is currently $901.00 thousand, with the most recent change of +$181.00 thousand (+25.14%) on 31 December 2023. During the last 3 years, it has fallen by -$9.10 million (-90.99%). DTIL annual accounts receivable is now -90.99% below its all-time high of $10.00 million, reached on 31 December 2020.DTIL Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$188.00 K
-$19.00 K-9.18%
30 September 2024
Summary:
Precision BioSciences quarterly accounts receivable is currently $188.00 thousand, with the most recent change of -$19.00 thousand (-9.18%) on 30 September 2024. Over the past year, it has dropped by -$3.32 million (-94.64%). DTIL quarterly accounts receivable is now -99.63% below its all-time high of $50.51 million, reached on 30 June 2022.DTIL Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DTIL Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.1% | -94.6% |
| 3 y3 years | -91.0% | -61.5% |
| 5 y5 years | +72.3% | -24.8% |
DTIL Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -91.0% | +84.6% | -99.6% | at low |
| 5 y | 5 years | -91.0% | +84.6% | -99.6% | +126.5% |
| alltime | all time | -91.0% | -99.6% | +126.5% |
Precision BioSciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $188.00 K(-9.2%) |
| June 2024 | - | $207.00 K(-46.9%) |
| Mar 2024 | - | $390.00 K(-56.7%) |
| Dec 2023 | $901.00 K(+25.1%) | $901.00 K(-74.3%) |
| Sept 2023 | - | $3.51 M(+438.3%) |
| June 2023 | - | $652.00 K(-6.1%) |
| Mar 2023 | - | $694.00 K(-3.6%) |
| Dec 2022 | $720.00 K(+47.5%) | $720.00 K(+0.7%) |
| Sept 2022 | - | $715.00 K(-98.6%) |
| June 2022 | - | $50.51 M(>+9900.0%) |
| Mar 2022 | - | $488.00 K(0.0%) |
| Dec 2021 | $488.00 K | $488.00 K(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $488.00 K(0.0%) |
| June 2021 | - | $488.00 K(-97.5%) |
| Mar 2021 | - | $19.26 M(+92.6%) |
| Dec 2020 | $10.00 M(+936.3%) | $10.00 M(-1.1%) |
| Sept 2020 | - | $10.12 M(>+9900.0%) |
| June 2020 | - | $83.00 K(-97.8%) |
| Mar 2020 | - | $3.86 M(+299.8%) |
| Dec 2019 | $965.00 K(+84.5%) | $965.00 K(+286.0%) |
| Sept 2019 | - | $250.00 K(0.0%) |
| June 2019 | - | $250.00 K(-95.9%) |
| Mar 2019 | - | $6.16 M(+1077.2%) |
| Dec 2018 | $523.00 K(>+9900.0%) | $523.00 K |
| Dec 2017 | $0.00 | - |
FAQ
- What is Precision BioSciences annual accounts receivable?
- What is the all time high annual accounts receivable for Precision BioSciences?
- What is Precision BioSciences annual accounts receivable year-on-year change?
- What is Precision BioSciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Precision BioSciences?
- What is Precision BioSciences quarterly accounts receivable year-on-year change?
What is Precision BioSciences annual accounts receivable?
The current annual accounts receivable of DTIL is $901.00 K
What is the all time high annual accounts receivable for Precision BioSciences?
Precision BioSciences all-time high annual accounts receivable is $10.00 M
What is Precision BioSciences annual accounts receivable year-on-year change?
Over the past year, DTIL annual accounts receivable has changed by +$181.00 K (+25.14%)
What is Precision BioSciences quarterly accounts receivable?
The current quarterly accounts receivable of DTIL is $188.00 K
What is the all time high quarterly accounts receivable for Precision BioSciences?
Precision BioSciences all-time high quarterly accounts receivable is $50.51 M
What is Precision BioSciences quarterly accounts receivable year-on-year change?
Over the past year, DTIL quarterly accounts receivable has changed by -$3.32 M (-94.64%)